Skip to main content

Table 2 Primary and secondary clinical outcomes assessed by EHR query

From: Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

 

Arm 1 KET

n = 13

Arm 2 NTX

n = 14

Arm 3 LA

n = 17

30-day hospital readmission (binary)

   

Count (%)

2 (15.38%)

3 (21.43%)

7 (41.18%)

RR to LA arm

0.3736

.5204

 
 

p = 0.17

p = 0.27

 

% of readmissions considered alcohol-related (post-hoc)

50.0%

100.0%

100.0%

30-day ED visit (binary)

   

Rate (%)

7 (53.85%)

8 (57.14%)

12 (70.59%)

RR to LA arm

.7629

.8095

 
 

p = 0.58

p = 0.69

 

14-day clinic attendance (binary)

   

Rate (%)

8 (61.54%)

7 (50.00%)

7 (41.18%)

RR to LA arm

1.4944

1.2142

 
 

p = 0.46

p = 0.90

Â